View More Recent Stories

Feb 21, 2023 07:00AM Presenting on the Emerging Growth Conference on February 22 Register Now
Feb 16, 2023 07:30AM Trevi Therapeutics to Present at the Emerging Growth Conference on February 22, 2023
Feb 2, 2023 07:30AM Trevi Therapeutics to Present and Participate in Upcoming February Conferences
Jan 25, 2023 09:00AM Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
Jan 5, 2023 04:05PM Trevi Therapeutics Provides Business Update Ahead of Upcoming Conferences
Dec 19, 2022 04:05PM Trevi Therapeutics to Present and Participate in Upcoming Conferences in San Francisco During the 41st Annual J.P. Morgan Health Care Conference
Nov 14, 2022 04:06PM Trevi Therapeutics (TRVI) Appoints David Clark as Chief Medical Officer
Nov 14, 2022 04:05PM Trevi Therapeutics Appoints Pharma Industry Veteran as Chief Medical Officer
Nov 10, 2022 04:05PM Trevi Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
Nov 8, 2022 07:30AM Trevi Therapeutics to Participate at the Stifel 2022 Healthcare Conference
Nov 3, 2022 04:05PM Trevi Therapeutics to Report Q3 2022 Financial Results and Provide a Corporate Update on November 10, 2022
Oct 27, 2022 07:30AM Trevi Therapeutics to Present Final Data from Phase 2 Trial of Oral Nalbuphine Extended Release for Chronic Cough in IPF at BTS' Winter Meeting
View More Recent Stories